Dual optimization in single-isocenter radiosurgery for multiple brain metastases: a dosimetric planning study
Open Access
- 5 August 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1901196
Abstract
Background: This study evaluated a dual-optimization strategy for single-isocenter multiple-target stereotactic radiosurgery (SIMT-SRS) in patients with multiple brain metastases, combining target-anchored isocenter placement with individualized dose prescription for each planning target volume (PTV). Methods: Three volumetric modulated arc therapy-based SIMT-SRS planning techniques were compared in 22 patients harboring 5–10 brain metastases: geometric center isocenter with composite dose prescription (GCI-Comp), target-anchored isocenter with composite dose prescription (TAI-Comp), and target-anchored isocenter with individual dose prescription (TAI-Ind). Dosimetric parameters for PTVs and organs at risk (OARs) were extracted and compared using the Friedman test followed by Bonferroni-corrected post hoc analyses. Results: All three techniques achieved equivalent target coverage (V95% > 99%, p = 0.202), plan quality (Q RTOG , p = 0.385), and conformity (CI Paddick , p = 0.546). Compared to GCI-Comp and TAI-Comp, TAI-Ind produced significantly higher intratumoral dose escalation (PTV–D max : 2025.60 vs. 2113.80 vs. 2241.34 cGy, p < 0.001) while achieving a significantly steeper dose gradient (R 50% : 13.43 vs. 12.07 vs. 10.31; GI Paddick : 12.91 vs. 12.10 vs. 9.41; both p < 0.001). TAI-Ind also resulted in the lowest normal brain dose exposure (V12Gy: 35.53 cm 3 ; D 50% : 322.36 cGy) and significantly reduced maximum doses to the hippocampus, brainstem, spinal canal, and bilateral cochleae (all p < 0.001). These dosimetric advantages were achieved at the expense of requiring a higher number of monitor units (6013.84 vs. 6494.89 vs. 7268.92, p < 0.001). Conclusions: The TAI-Ind dual-optimization strategy provided greater intratumoral dose escalation and more favorable OARs sparing compared with the composite-prescription techniques, without compromising target coverage. This approach represents a promising strategy for SIMT-SRS planning in patients with multiple brain metastases, warranting further clinical validation.Keywords
This publication has 38 references indexed in Scilit:
- Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004–2020)Journal of Neuro-Oncology, 2025
- Frameless stereotactic radiosurgery for brain metastasis: a systematic review and meta-analysisNeurosurgical Review, 2024
- Treatment Options for Brain MetastasesCurrent Treatment Options in Oncology, 2024
- A novel dose fall‐off index and preliminary application in brain and lung stereotactic radiotherapyMedical Physics, 2023
- Optimization of isocenter position for multiple targets with nonuniform‐margin expansionJournal of Applied Clinical Medical Physics, 2022
- Single isocenter stereotactic irradiation for multiple brain metastases: current situation and prospectsJapanese Journal of Radiology, 2022
- Comparison of dosimetric impact of intra‐fractional setup discrepancy between multiple‐ and single‐isocenter approaches in linac‐based stereotactic radiotherapy of multiple brain metastasesJournal of Applied Clinical Medical Physics, 2021
- Dosimetric impact of rotational errors on the quality of VMAT‐SRS for multiple brain metastases: Comparison between single‐ and two‐isocenter treatment planning techniquesJournal of Applied Clinical Medical Physics, 2020
- ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beamsStrahlentherapie und Onkologie, 2019
- Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical resultsLa radiologia medica, 2017